List view / Grid view
6 May 2015 | By Victoria White
GSK, Telethon and OSR have submitted a marketing application to the EMA for a gene therapy to treat patients with a rare disease, ADA-SCID...
6 May 2015 | By Victoria White
Teva has acquired Auspex Pharmaceuticals through the successful tender offer for all of the outstanding Auspex shares at $101.00 per share...
6 May 2015 | By Victoria White
Lilly is set to establish a new drug delivery and device innovation centre in Cambridge, increasing its delivery and devise R&D space by almost 50%...
6 May 2015 | By Victoria White
Indivior has announced top-line results from its Phase 3 clinical trial of RBP-7000, an investigational drug for the treatment of schizophrenia...
6 May 2015 | By
Acacia Pharma has announced positive results from its Phase 2 study of APD403 in the prevention of chemotherapy-induced nausea & vomiting (CINV)...
6 May 2015 | By Victoria White
NDA Group's new Infographic looks at drug approvals in 2014 and highlights the fact that nearly 40% of approved products came from non top pharma companies...
6 May 2015 | By Victoria White
A handheld device that identifies pressure ulcers in the earliest stage of their development has saved two UK NHS hospitals £50,000 per month during trials...
6 May 2015 | By Victoria White
All resolutions presented at Cardio3 BioSciences' Annual Shareholder Assembly were duly passed including a name change for the Company to Celyad...
5 May 2015 | By Cobalt Light System
Cobalt Light Systems has received a European Union grant to investigate revolutionary high-speed quantitative analysis in pharmaceutical manufacturing...
5 May 2015 | By Victoria White
WHO and UNHCR have produced mhGAP-HIG so non-specialist health workers can better manage mental health needs of those impacted by humanitarian emergencies...
5 May 2015 | By Victoria White
Scientists have identified chemical markers in urine associated with body mass, providing insights into how obesity causes disease...
5 May 2015 | By Victoria White
Clazakizumab has met its primary endpoint in a follow-on Phase 2b clinical trial in adults with moderate to severe rheumatoid arthritis...
5 May 2015 | By Victoria White
Vernalis and Tris Pharma have announced that the FDA has approved the New Drug Application for Tuzistra XR extended-release oral suspension...
5 May 2015 | By Victoria White
A patient has become the first to receive a new ‘resistance-busting’ panRAF inhibitor with the launch of a phase I clinical trial...
5 May 2015 | By Victoria White
Eli Lilly and Company has released two new reports that provide a comprehensive overview of the Company's corporate responsibility efforts...
